Cargando…
Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study
OBJECTIVES: Since 2007, human papillomavirus (HPV) vaccines have been administered for the prevention of cervical cancer in Korea. We investigated the status of HPV vaccination among HPV-infected adult women with abnormal cervical cytology before the introduction of National Immunization Program. ME...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918886/ https://www.ncbi.nlm.nih.gov/pubmed/31788994 http://dx.doi.org/10.3802/jgo.2020.31.e4 |
_version_ | 1783480674630500352 |
---|---|
author | Seong, Jaehyun Ryou, Sangmi Yoo, Myeongsu Lee, JeongGyu Kim, Kisoon Jee, Youngmee Cho, Chi Heum Kim, Seok Mo Hong, Sung Ran Jeong, Dae Hoon Lee, Won-Chul Park, Jong Sup Kim, Tae Jin Kee, Mee-Kyung |
author_facet | Seong, Jaehyun Ryou, Sangmi Yoo, Myeongsu Lee, JeongGyu Kim, Kisoon Jee, Youngmee Cho, Chi Heum Kim, Seok Mo Hong, Sung Ran Jeong, Dae Hoon Lee, Won-Chul Park, Jong Sup Kim, Tae Jin Kee, Mee-Kyung |
author_sort | Seong, Jaehyun |
collection | PubMed |
description | OBJECTIVES: Since 2007, human papillomavirus (HPV) vaccines have been administered for the prevention of cervical cancer in Korea. We investigated the status of HPV vaccination among HPV-infected adult women with abnormal cervical cytology before the introduction of National Immunization Program. METHODS: From 2010 to 2016, HPV-positive women (age, 20–60 years) with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion (LSIL) were enrolled from five hospitals across Korea. Their HPV genotype, epidemiologic, and clinical data, including HPV vaccination history, were obtained. We compared the epidemiological characteristics and prevalence of HPV-16/18 genotypes between vaccinated and unvaccinated women. RESULTS: Among the 1,300 women, approximately 26% had a history of vaccination. Vaccinated patients were significantly younger, unmarried, and had a higher education level than unvaccinated women. For HPV-vaccinated individuals by vaccine dose, there was a significant younger age at vaccination initiation (p=0.025), longer duration from HPV vaccination to Pap test date (p=0.001), and lower proportion of HPV-16/18 (p=0.028) in the women with three doses. There was a significantly lower prevalence of HPV-16/18 genotypes in women who were vaccinated at least 12 months prior than in unvaccinated women (adjusted prevalence ratio [aPR]=0.51; 95% confidence interval [CI]=0.29–0.88). For women with LSIL, the prevalence of the HPV-16/18 genotypes was significantly lower in women who were vaccinated more than 12 months prior than in unvaccinated women (aPR=0.35; 95% CI=0.13–0.96). CONCLUSION: This study highlighted the status of HPV vaccination and the prevalence of HPV-16/18 genotypes among HPV-infected women with abnormal cervical cytology according to HPV vaccination. It provides preliminary information regarding the status of HPV vaccination among Korean adult women. |
format | Online Article Text |
id | pubmed-6918886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-69188862020-01-01 Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study Seong, Jaehyun Ryou, Sangmi Yoo, Myeongsu Lee, JeongGyu Kim, Kisoon Jee, Youngmee Cho, Chi Heum Kim, Seok Mo Hong, Sung Ran Jeong, Dae Hoon Lee, Won-Chul Park, Jong Sup Kim, Tae Jin Kee, Mee-Kyung J Gynecol Oncol Original Article OBJECTIVES: Since 2007, human papillomavirus (HPV) vaccines have been administered for the prevention of cervical cancer in Korea. We investigated the status of HPV vaccination among HPV-infected adult women with abnormal cervical cytology before the introduction of National Immunization Program. METHODS: From 2010 to 2016, HPV-positive women (age, 20–60 years) with atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion (LSIL) were enrolled from five hospitals across Korea. Their HPV genotype, epidemiologic, and clinical data, including HPV vaccination history, were obtained. We compared the epidemiological characteristics and prevalence of HPV-16/18 genotypes between vaccinated and unvaccinated women. RESULTS: Among the 1,300 women, approximately 26% had a history of vaccination. Vaccinated patients were significantly younger, unmarried, and had a higher education level than unvaccinated women. For HPV-vaccinated individuals by vaccine dose, there was a significant younger age at vaccination initiation (p=0.025), longer duration from HPV vaccination to Pap test date (p=0.001), and lower proportion of HPV-16/18 (p=0.028) in the women with three doses. There was a significantly lower prevalence of HPV-16/18 genotypes in women who were vaccinated at least 12 months prior than in unvaccinated women (adjusted prevalence ratio [aPR]=0.51; 95% confidence interval [CI]=0.29–0.88). For women with LSIL, the prevalence of the HPV-16/18 genotypes was significantly lower in women who were vaccinated more than 12 months prior than in unvaccinated women (aPR=0.35; 95% CI=0.13–0.96). CONCLUSION: This study highlighted the status of HPV vaccination and the prevalence of HPV-16/18 genotypes among HPV-infected women with abnormal cervical cytology according to HPV vaccination. It provides preliminary information regarding the status of HPV vaccination among Korean adult women. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019-06-28 /pmc/articles/PMC6918886/ /pubmed/31788994 http://dx.doi.org/10.3802/jgo.2020.31.e4 Text en Copyright © 2020. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Seong, Jaehyun Ryou, Sangmi Yoo, Myeongsu Lee, JeongGyu Kim, Kisoon Jee, Youngmee Cho, Chi Heum Kim, Seok Mo Hong, Sung Ran Jeong, Dae Hoon Lee, Won-Chul Park, Jong Sup Kim, Tae Jin Kee, Mee-Kyung Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title | Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title_full | Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title_fullStr | Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title_full_unstemmed | Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title_short | Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study |
title_sort | status of hpv vaccination among hpv-infected women aged 20–60 years with abnormal cervical cytology in south korea: a multicenter, retrospective study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918886/ https://www.ncbi.nlm.nih.gov/pubmed/31788994 http://dx.doi.org/10.3802/jgo.2020.31.e4 |
work_keys_str_mv | AT seongjaehyun statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT ryousangmi statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT yoomyeongsu statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT leejeonggyu statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT kimkisoon statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT jeeyoungmee statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT chochiheum statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT kimseokmo statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT hongsungran statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT jeongdaehoon statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT leewonchul statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT parkjongsup statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT kimtaejin statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy AT keemeekyung statusofhpvvaccinationamonghpvinfectedwomenaged2060yearswithabnormalcervicalcytologyinsouthkoreaamulticenterretrospectivestudy |